☰

Harrison N. Jones, Ph.D. - Publications

Affiliations: 
2007 University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Speech Pathology, Rehabilitation and Therapy
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Cohen SM, Porter Starr KN, Risoli T, Lee HJ, Misono S, Jones H, Raman S. Association between Dysphagia and Surgical Outcomes across the Continuum of Frailty. Journal of Nutrition in Gerontology and Geriatrics. 1-21. PMID 34048333 DOI: 10.1080/21551197.2021.1929644  0.688
2020 Korlimarla A, Spiridigliozzi GA, Crisp K, Herbert M, Chen S, Malinzak M, Stefanescu M, Austin SL, Cope H, Zimmerman K, Jones H, Provenzale JM, Kishnani PS. Novel approaches to quantify CNS involvement in children with Pompe disease. Neurology. PMID 32518148 DOI: 10.1212/Wnl.0000000000009979  0.695
2020 Crisp KD, Case LE, Kravitz RM, Kishnani PS, Jones HN. Training, detraining, and retraining: Two 12-week respiratory muscle training regimens in a child with infantile-onset Pompe disease. Journal of Pediatric Rehabilitation Medicine. PMID 32176666 DOI: 10.3233/Prm-190601  0.321
2020 Jones HN, Fernandes S, Hannah WB, Kansagra S, Raynor EM, Kishnani PS. Adenotonsillectomy should be avoided whenever possible in infantile-onset Pompe disease. Molecular Genetics and Metabolism Reports. 23: 100574. PMID 32090020 DOI: 10.1016/J.Ymgmr.2020.100574  0.344
2020 Khan AA, Case LE, Herbert M, DeArmey S, Jones H, Crisp K, Zimmerman K, ElMallah MK, Young SP, Kishnani PS. Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease: a clinical study and review of the literature. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 31904026 DOI: 10.1038/S41436-019-0738-0  0.701
2020 Khan AA, Case LE, Herbert M, DeArmey S, Jones H, Crisp K, Zimmerman K, ElMallah MK, Kishnani PS. Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease Molecular Genetics and Metabolism. 129. DOI: 10.1016/J.Ymgme.2019.11.219  0.35
2018 Jones H, Crisp K, Batten M, Edds A, Marcus J, Kuchibhalta M, Hobson-Webb L, Kishnani P. Lingual pathophysiology in late-onset Pompe disease Molecular Genetics and Metabolism. 123. DOI: 10.1016/J.Ymgme.2017.12.178  0.329
2017 Gil MA, Emberts Z, Jones H, St Mary CM. Social Information on Fear and Food Drives Animal Grouping and Fitness. The American Naturalist. 189: 227-241. PMID 28221835 DOI: 10.1086/690055  0.679
2016 Chan J, Desai AK, Kazi ZB, Corey K, Austin S, Hobson-Webb LD, Case LE, Jones HN, Kishnani PS. The emerging phenotype of late-onset Pompe disease: A systematic literature review. Molecular Genetics and Metabolism. PMID 28185884 DOI: 10.1016/J.Ymgme.2016.12.004  0.321
2016 Boentert M, Prigent H, Várdi K, Jones HN, Mellies U, Simonds AK, Wenninger S, Barrot Cortés E, Confalonieri M. Practical Recommendations for Diagnosis and Management of Respiratory Muscle Weakness in Late-Onset Pompe Disease. International Journal of Molecular Sciences. 17. PMID 27763517 DOI: 10.3390/Ijms17101735  0.304
2015 Kashyap MK, Kumar D, Jones H, Amaya-Chanaga CI, Choi MY, Melo-Cardenas J, Ale-Ali A, Kuhne MR, Sabbatini P, Cohen LJ, Shelat SG, Rassenti LZ, Kipps TJ, Cardarelli PM, Castro JE. Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway. Oncotarget. PMID 26646452 DOI: 10.18632/Oncotarget.6465  0.696
2015 Kashyap MK, Kumar D, Villa R, La Clair JJ, Benner C, Sasik R, Jones H, Ghia EM, Rassenti LZ, Kipps TJ, Burkart MD, Castro JE. Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B. Haematologica. 100: 945-54. PMID 25862704 DOI: 10.3324/Haematol.2014.122069  0.697
2015 Jones HN, Crisp KD, Asrani P, Sloane R, Kishnani PS. Quantitative assessment of lingual strength in late-onset Pompe disease. Muscle & Nerve. 51: 731-5. PMID 25399907 DOI: 10.1002/Mus.24523  0.319
2014 Jones HN, Crisp KD, Moss T, Strollo K, Robey R, Sank J, Canfield M, Case LE, Mahler L, Kravitz RM, Kishnani PS. Effects of respiratory muscle training (RMT) in children with infantile-onset Pompe disease and respiratory muscle weakness. Journal of Pediatric Rehabilitation Medicine. 7: 255-65. PMID 25260508 DOI: 10.3233/Prm-140294  0.318
2013 Hobson-Webb LD, Jones HN, Kishnani PS. Oropharyngeal dysphagia may occur in late-onset Pompe disease, implicating bulbar muscle involvement. Neuromuscular Disorders : Nmd. 23: 319-23. PMID 23332114 DOI: 10.1016/J.Nmd.2012.12.003  0.355
2012 Prater SN, Banugaria SG, DeArmey SM, Botha EG, Stege EM, Case LE, Jones HN, Phornphutkul C, Wang RY, Young SP, Kishnani PS. The emerging phenotype of long-term survivors with infantile Pompe disease. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 14: 800-10. PMID 22538254 DOI: 10.1038/Gim.2012.44  0.307
2011 Murdoch B, Whitehill T, Letter Md, Jones H. Communication impairments in parkinson's disease Parkinson's Disease. 2011: 234657-234657. PMID 22220286 DOI: 10.4061/2011/234657  0.707
2011 Dubrovsky A, Corderi J, Lin M, Kishnani PS, Jones HN. Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation. Muscle & Nerve. 44: 897-901. PMID 21953123 DOI: 10.1002/Mus.22202  0.331
2011 Jones HN, Story TJ, Collins TA, Dejoy D, Edwards CL. Multidisciplinary assessment and diagnosis of conversion disorder in a patient with foreign accent syndrome. Behavioural Neurology. 24: 245-55. PMID 21876264 DOI: 10.3233/Ben-2011-0332  0.303
2010 Jones HN, Kendall DL, Okun MS, Wu SS, Velozo C, Fernandez HH, Spencer KA, Rosenbek JC. Speech motor program maintenance, but not switching, is enhanced by left-hemispheric deep brain stimulation in Parkinson's disease. International Journal of Speech-Language Pathology. 12: 385-98. PMID 20586527 DOI: 10.3109/17549507.2010.491870  0.57
2010 Jones HN, Muller CW, Lin M, Banugaria SG, Case LE, Li JS, O'Grady G, Heller JH, Kishnani PS. Oropharyngeal dysphagia in infants and children with infantile Pompe disease. Dysphagia. 25: 277-83. PMID 19763689 DOI: 10.1007/S00455-009-9252-X  0.372
2009 Muller CW, Jones HN, O'Grady G, Suárez AH, Heller JH, Kishnani PS. Language and speech function in children with infantile Pompe disease Journal of Pediatric Neurology. 7: 147-156. DOI: 10.3233/Jpn-2009-0291  0.335
2009 Jones HN. Prosody in Parkinson's Disease Perspectives On Neurophysiology and Neurogenic Speech and Language Disorders. 19: 77-82. DOI: 10.1044/Nnsld19.3.77  0.331
Show low-probability matches.